Bls Pharmaceuticals (ASX:BLS) - Key People
ASX:BLS · Directors, executives and key personnel · 12 month lookback
S Watson
Current
Managing Director, CEO
Mentioned in
Healthcare Wrap - Week 36 (31 Aug -> 4 Sept) 2026
5 Sept 2026
BLS Pharmaceuticals Doubles Revenue and Profit in FY26, Secures $50m German Contract
31 Aug 2026
Market Wrap - Week 31 (27 July -> 31 July) 2026
1 Aug 2026
Healthcare Wrap - Week 31 (27 July -> 31 July) 2026
1 Aug 2026
Samuel Watson
Current
Managing Director, CEO
Mentioned in
Market Wrap - Week 36 (31 Aug -> 4 Sept) 2026
5 Sept 2026
BLS Pharmaceuticals Doubles Revenue and Profit in FY26, Secures $50m German Contract
31 Aug 2026
Healthcare Wrap - Week 31 (27 July -> 31 July) 2026
1 Aug 2026
BLS Pharmaceuticals Posts Record $22.5m Q4 Revenue, Expands Global Manufacturing Footprint
30 July 2026
Also Mentioned
People named in Bls Pharmaceuticals (ASX:BLS) articles over the last 12 months, by frequency.
Edward Myer
· 6 articles
Melissa Tempra
· 6 articles
Anthony Ho
· 4 articles
Jason Hine
· 4 articles
Guy Robertson
· 4 articles
Paul Mitchell
· 3 articles
Jason Evans
· 2 articles
S Watson - Managing Director and Chief Executive Officer
· 1 article
Edward Myer - Non-Executive Director
· 1 article
Angus Walker - Alternate Director and Chief Investment Officer of MWP Partners
· 1 article
Melissa Tempra - Media and Investor Relations, NWR Communications
· 1 article